Need to improve thromboprophylaxis across the continuum of care for surgical patients

Advances in Therapy

Volumn 27, Issue 2, 2010, Pages 81-93

  Amin, Alpesh N ^c   Lin, Jay ^a   Ryan, Amy ^b  

^a SANOFI   (France)

^b Premier Inc   (United States)

^c NONE

Author keywords

Abdominal surgery; Anticoagulation; Orthopedic surgery; Prophylaxis; Venous thromboembolism

Indexed keywords

ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; ANTITHROMBIN; ARGATROBAN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; TINZAPARIN; WARFARIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG CONTRAINDICATION; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; ORTHOPEDIC SURGERY; OUTPATIENT CARE; PATIENT CARE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; SURGEON; SURGICAL PATIENT; THROMBOSIS PREVENTION; TREATMENT DURATION; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; CONTINUITY OF PATIENT CARE; DRUG UTILIZATION; FEMALE; HOSPITAL BED CAPACITY; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOEMBOLISM;

EID: 77953019837     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0015-8     Document Type: Article

References (35)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl.):381S-453S.
2. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82:777-782.
3. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. September 15, 2008. Available at: www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to- action-on-dvt-2008.pdf. Accessed: February 23, 2010.
4. Centers for Medicare and Medicaid Services. Reporting Hospital Quality Data for Annual Payment Update. Available at: www.cms.hhs.gov/ HospitalQualityInits/08-HospitalRHQDAPU.asp. Accessed February 23, 2010.
5. HCUP NIS Related Reports. Healthcare Cost and Utilization Project (HCUP). September 2008. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/db/nation/nis/nisrelatedreports.jsp. Accessed February 23, 2010.
6. Anderson FA Jr., Hirsh J, White K, Fitzgerald RH Jr.; Hip and Knee Registry Investigators. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest. 2003;124:349S-356S.
7. Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. J Thromb Thrombolysis. 2009;28:458-464.
8. Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2003;163:1337-1342.
9. Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand. 2000;71:47-50.
10. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158:1525-1531.
11. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients undergoing total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet. 1996;348:224-228.
12. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-394.
13. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64:69-76.
14. Amin AN, Stemkowski S, Lin J, Yang G. Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost. 2008;99:796-797.
15. Amin A, Stemkowski S, Lin J, Yang G. Appropriate thromboprophylaxis in hospitalized cancer patients. Clin Adv Hematol Oncol. 2008;6:910-920.
16. Amin A, Spyropoulos AC, Dobesh P, et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis. 2010;29:326-339.
17. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936-945.
18. Rahme E, Dasgupta K, Burman M, et al. Postdischarge thromboprophylaxis and mortality risk after hip- or knee-replacement surgery. CMAJ. 2008;178:1545-1554.
19. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl.):338S-400S.
20. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167:1471-1475.
21. Lassen MR, Borris LC, Anderson BS, et al. Efficacy and safety of prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after total hip arthroplasty- the Danish Prolonged Prophylaxis (DaPP) Study. Thromb Res. 1998;89:281-287.
22. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery- results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost. 1997;77:26-31.
23. Bergqvist D, Benoni G, Björgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med. 1996;335:696-700.
24. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135:858-869.
25. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet. 2001;358:9-15.
26. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384-2390.
27. Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;(1):CD004318.
28. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980. (Pubitemid 34983247)
29. Huo MH, Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther. 2009;31:1129-1141.
30. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition). Chest. 2008;133(6 suppl.):160S-198S. (Pubitemid 351892967)
31. Schuringa P, Yen D. Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty. Can J Surg. 1999;42:360-362.
32. Hirsh J, Bauer KA, Donati MB, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl.):141S-159S. (Pubitemid 351892966)
33. Colorado Foundation for Medical Care. Surgical Care Improvement Project (SCIP). Available at: www.cfmc.org/hospital/hospital-scip.htm. Accessed February 23, 2010.
34. National Quality Forum. NQF-Endorsed®Standards. Available at: www.qualityforum.org/Measures-List.aspx Accessed February 23, 2010.
35. The Joint Commission. Performance Measurement Initiatives. Venous Thromboembolism (VTE) Core Measures Set. Last updated 4/2009. Available at: www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htm. Accessed February 23, 2010.